loadpatents
Patent applications and USPTO patent grants for DEMARTINO; Michael P..The latest application filed is for "chemical compounds".
Patent | Date |
---|---|
Chemical Compounds App 20210253528 - DEMARTINO; Michael P. ;   et al. | 2021-08-19 |
N-(3-(2-(4-chlorophenoxy)acetamido)bicyclo[1.1.1] Pentan-1-yl)-2-cyclobutane-1- Carboxamide Derivatives And Related Compounds As Atf4 Inhibitors For Treating Cancer And Other Diseases App 20210145771 - CHEUNG; Mui ;   et al. | 2021-05-20 |
Chemical Compounds as ATF-4 Pathway Inhibitors App 20210093619 - AXTEN; Jeffrey Michael ;   et al. | 2021-04-01 |
Chemical compounds Grant 10,851,053 - Axten , et al. December 1, 2 | 2020-12-01 |
Chemical Compounds App 20200297710 - AXTEN; Jeffrey Michael ;   et al. | 2020-09-24 |
Compounds as rearranged during transfection (RET) inhibitors Grant 10,709,695 - Demartino , et al. | 2020-07-14 |
2-(4-chlorophenoxy)-n-((1 -(2-(4-chlorophenoxy)ethynazetidin-3-yl)methyl)acetamide Derivatives And Related Compounds As Atf4 Inh App 20200140383 - CHEUNG; Mui ;   et al. | 2020-05-07 |
Chemical Compounds App 20190298705 - AXTEN; Jeffrey Michael ;   et al. | 2019-10-03 |
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20190247382 - Demartino; Michael P. ;   et al. | 2019-08-15 |
Compounds as rearranged during transfection (RET) inhibitors Grant 10,294,236 - Cheung , et al. | 2019-05-21 |
Compounds as rearranged during transfection (RET) inhibitors Grant 10,292,975 - Demartino , et al. | 2019-05-21 |
Chemical Compounds App 20190144384 - AXTEN; Jeffrey Michael ;   et al. | 2019-05-16 |
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20190022078 - DEMARTINO; Michael P. ;   et al. | 2019-01-24 |
Compounds as rearranged during transfection (RET) inhibitors Grant 10,111,866 - Demartino , et al. October 30, 2 | 2018-10-30 |
Amino quinazolines as kinase inhibitors Grant 9,994,529 - Bury , et al. June 12, 2 | 2018-06-12 |
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20180147194 - DEMARTINO; Michael P. ;   et al. | 2018-05-31 |
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20180099976 - Cheung; Mui ;   et al. | 2018-04-12 |
Pyridone derivatives as rearranged during transfection (RET) kinase inhibitors Grant 9,918,974 - Demartino , et al. March 20, 2 | 2018-03-20 |
Compounds as rearranged during transfection (RET) inhibitors Grant 9,879,021 - Cheung , et al. January 30, 2 | 2018-01-30 |
Pyridone Derivatives As Rearranged During Transfection (ret) Kinase Inhibitors App 20170340617 - DEMARTINO; Michael P. ;   et al. | 2017-11-30 |
Novel Compounds As Rearranged During Transfection (ret) Inhibitors App 20170298074 - CHEUNG; Mui ;   et al. | 2017-10-19 |
Amino Quinazolines As Kinase Inhibitors App 20170152233 - BURY; Michael Jonathan ;   et al. | 2017-06-01 |
Quinazolines as kinase inhibitors Grant 9,650,364 - Casillas , et al. May 16, 2 | 2017-05-16 |
Amino quinazolines as kinase inhibitors Grant 9,604,938 - Bury , et al. March 28, 2 | 2017-03-28 |
Amino-quinolines As Kinase Inhibitors App 20160060222 - BURY; Michael Jonathan ;   et al. | 2016-03-03 |
Amino-quinolines as kinase inhibitors Grant 9,216,965 - Casillas , et al. December 22, 2 | 2015-12-22 |
Quinazolines As Kinase Inhibitors App 20150361069 - CASILLAS; Linda N. ;   et al. | 2015-12-17 |
Amino-quinolines As Kinase Inhibitors App 20150094333 - Casillas; Linda N. ;   et al. | 2015-04-02 |
Amino Quinazolines As Kinase Inhibitors App 20140206688 - Bury; Michael Jonathan ;   et al. | 2014-07-24 |
Amino-quinolines As Kinase Inhibitors App 20130053375 - Bury; Michael Jonathan ;   et al. | 2013-02-28 |
Imidazolyl-imidazoles As Kinase Inhibitors App 20130018039 - Bodmer; Vera Q. ;   et al. | 2013-01-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.